Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.
Saved in:
| Title: | Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms. |
|---|---|
| Authors: | Zargari M; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Nayak N; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Canonico M; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Patel PC; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Fedorov K; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Walsh KJ; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Kishtagari A; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Mohan SR; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Savona MR; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt University School of Medicine, Nashville, TN, USA., Ball S; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 1152-1155. Date of Electronic Publication: 2025 Nov 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41293791 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zargari+M%22">Zargari M</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Nayak+N%22">Nayak N</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Canonico+M%22">Canonico M</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Patel+PC%22">Patel PC</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Fedorov+K%22">Fedorov K</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+KJ%22">Walsh KJ</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Kishtagari+A%22">Kishtagari A</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Mohan+SR%22">Mohan SR</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Savona+MR%22">Savona MR</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Ball+S%22">Ball S</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 1152-1155. <i>Date of Electronic Publication: </i>2025 Nov 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41293791 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2025.2592781 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1152 Titles: – TitleFull: Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zargari M – PersonEntity: Name: NameFull: Nayak N – PersonEntity: Name: NameFull: Canonico M – PersonEntity: Name: NameFull: Patel PC – PersonEntity: Name: NameFull: Fedorov K – PersonEntity: Name: NameFull: Walsh KJ – PersonEntity: Name: NameFull: Kishtagari A – PersonEntity: Name: NameFull: Mohan SR – PersonEntity: Name: NameFull: Savona MR – PersonEntity: Name: NameFull: Ball S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 67 – Type: issue Value: 5 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |